Yang R, Li R, Niu X, Zhao Y, et al. Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study. Oral Oncol 2024;158:106981.
PMID: 39142147